Incontinentia Pigmenti (Bloch-Sulzberger Syndrome)

Incontinentia pigmenti (IP), also known as Bloch-Sulzberger syndrome (described by Bruno Bloch in 1926 and Marion Sulzberger in 1928), is a rare X-linked dominant genodermatosis characterized by characteristic cutaneous findings evolving through sequential stages, often associated with abnormalities in other ectodermal-derived structures (teeth, eyes, central nervous system, hair, nails). Genetics: caused by loss-of-function mutations in IKBKG gene (formerly called NEMO, NF-kB Essential Modulator) located on chromosome Xq28. The IKBKG protein is essential for activation of the NF-kB transcription factor pathway involved in immunity, inflammation, and apoptosis regulation. The most common mutation is a recurrent deletion of exons 4-10 (60-80% of cases). Inheritance: X-linked dominant with male lethality. Affected hemizygous males die in utero (presumed second trimester pregnancy loss in 25-30% of pregnancies of affected mothers). The condition is observed almost exclusively in heterozygous females, with phenotypic variability explained by skewed X-inactivation (lyonization). Surviving males have either: Klinefelter syndrome (47,XXY karyotype, second X protects from lethality), postzygotic somatic mosaicism (mutation in subset of cells), or hypomorphic mutation with partial function. About 50-65% of cases are sporadic (de novo mutations in mother), 35-50% inherited from affected mother.

Cutaneous manifestations evolve through 4 sequential stages following Blaschko lines (lines of embryonic neuroectodermal migration, distinct from dermatomes): Stage 1 (vesicular or inflammatory): birth to 4 months. Erythematous papules, vesicles, bullae, and pustules in linear, swirling pattern along Blaschko lines, predominantly on extremities and trunk. May persist or recur with intercurrent infections. Histology shows eosinophilic spongiosis (eosinophils in epidermis), and high peripheral blood eosinophilia (15-65%) is characteristic. Stage 2 (verrucous): 2-6 months. Warty, hyperkeratotic, linear plaques replacing the vesicular lesions, also along Blaschko lines, primarily on extremities. Histology shows hyperkeratosis, papillomatosis, and dyskeratotic cells. Stage 3 (hyperpigmented): 3-6 months through adolescence to age 16 (most characteristic). Characteristic 'splashed paint' or 'marble cake' or 'Chinese figures' pattern of brown to gray-brown hyperpigmentation along Blaschko lines, predominantly on trunk and extremities. The pigmentation results from melanin 'incontinence' from epidermis into dermis (giving the syndrome its name). Histology shows melanin droplets in dermal melanophages. Stage 4 (hypopigmented atrophic): adolescence and adulthood. Pale, hairless, atrophic linear streaks (particularly on lower extremities and posterior calves), with absent eccrine sweat glands and hair follicles. Often the only persistent skin manifestation in adults. Stages may overlap, and not all patients exhibit all 4 stages.

Associated systemic abnormalities: (1) Dental (80%): hypodontia (missing teeth), microdontia (small teeth), conical/peg-shaped teeth, delayed eruption, defective enamel. (2) Ocular (35-77%): retinal vascular abnormalities are most serious — peripheral retinal avascularity, neovascularization, retinal detachment (10-30% of patients, risk of blindness, requires URGENT neonatal ophthalmologic exam and prophylactic laser photocoagulation), other findings include cataract, optic atrophy, strabismus, microphthalmia, foveal hypoplasia. (3) Central nervous system (30%): seizures in first year of life, infantile spasms, focal seizures, intellectual disability, microcephaly, spastic paralysis, cerebellar ataxia, cerebral atrophy, periventricular white matter changes, encephalopathy from cerebrovascular accident in neonate or infant (sudden hemiparesis or coma). (4) Hair: alopecia (especially vertex), woolly hair, sparse eyebrows and eyelashes, scarring alopecia. (5) Nails: dystrophy, ridging, pitting, painful subungual keratotic tumors. (6) Other: heart defects (rare), supernumerary nipples, breast hypoplasia. Diagnostic criteria (Landy and Donnai 1993, revised by Minic 2014): in absence of family history, requires at least 2 major criteria (typical neonatal vesicular rash with eosinophilia, hyperpigmentation along Blaschko lines, atrophic hairless pale streaks); minor criteria include dental abnormalities, alopecia, nail dystrophy, retinal disease, and CNS abnormalities. With positive family history (mother), even single major criterion is sufficient. Genetic testing for IKBKG mutation confirms diagnosis. Workup at diagnosis: detailed skin exam to identify stage and Blaschko distribution, dental exam (referral to pediatric dentist), URGENT ophthalmologic exam in neonates within first month for retinal vascular evaluation (RetCam imaging) — repeat every 1-3 months in infancy, then annually, with prophylactic laser photocoagulation for ischemic retinal areas; neurologic exam and consideration of brain MRI if neurologic symptoms; cardiology screening; genetic counseling. Treatment is supportive: skin (mild topical corticosteroids for inflammatory phase, emollients, sun protection); dental (restoration, prosthetics, orthodontics); ophthalmologic (laser ablation of avascular retina, vitrectomy for detachment, early intervention prevents blindness); neurologic (antiepileptics for seizures, supportive care for intellectual disability, physical/occupational therapy); genetic counseling for affected families. Pregnancy in affected women requires prenatal counseling regarding 25% risk of miscarriage of male fetus, 25% risk of affected female, 50% risk of unaffected child. Prenatal testing available for known familial mutation.